Social media platforms are awash with claims that nattokinase, an enzyme derived from the traditional Japanese food natto, can act as a potent agent for clearing arterial plaque. These advertisements paint a picture of a simple dietary shortcut to cardiovascular health. However, a closer examination of the scientific literature, undertaken by science-focused YouTuber Mic the Vegan, suggests that the reality is far more nuanced. With a Master’s degree in Public Health, Mic the Vegan delves into the available research, scrutinizing whether the enthusiasm surrounding nattokinase for plaque reduction is truly warranted.

Understanding Natto and Nattokinase: A Culinary and Scientific Intersection

Natto, a cornerstone of Japanese cuisine, is produced by fermenting whole soybeans with specific strains of Bacillus bacteria. Traditionally, this fermentation was carried out in rice straw bundles, a process that imbues natto with its characteristic sticky texture and yields approximately 1,000 to 2,000 units of nattokinase per serving. Modern commercial production often utilizes aerated vats, followed by extraction and refinement of the nattokinase enzyme. Some supplements boast significantly higher concentrations, reaching up to 10,000 units, and notably, this refining process often removes vitamin K2, a crucial nutrient found abundantly in whole natto.

Soybeans are an ideal substrate for this fermentation process due to their high protein content, which serves as the essential nutrient source for the bacteria. Nattokinase itself is a protease, an enzyme capable of breaking down proteins. What makes nattokinase particularly intriguing to researchers is its remarkable ability to survive the digestive process. Despite being a relatively large protein molecule, composed of 275 amino acids, nattokinase appears to resist the acidic environment of the stomach and can traverse the intestinal wall to enter the bloodstream. This journey is unusual, as the body typically absorbs nutrients in the form of individual amino acids or shorter peptide chains. Mic the Vegan highlights that nattokinase seems to utilize a cellular transport mechanism, specifically endocytosis, suggesting a targeted absorption rather than a passive process. He emphasizes that this entry into the bloodstream is not indicative of a "leaky gut" phenomenon but rather a specific biological pathway.

Population Studies: The Observational Link Between Natto Consumption and Cardiovascular Health

Population studies, particularly those conducted in Japan, have provided compelling, albeit observational, data linking natto consumption to improved cardiovascular health outcomes. A significant 2017 study involving approximately 30,000 participants revealed a statistically significant association between regular natto consumption and a 25% lower risk of death from cardiovascular disease. This research further indicated that while total soy protein intake was associated with a 25% reduction in stroke-related mortality, natto consumption specifically correlated with a 32% lower risk.

A separate, large-scale study examining nearly 90,000 middle-aged adults found that individuals with the highest intake of natto exhibited a 24% lower risk of death from cardiovascular disease. Interestingly, tofu also demonstrated a positive association, with high consumers showing a 26% lower risk of heart disease mortality. These findings suggest a broader benefit associated with soy consumption, leading Mic the Vegan to conclude that "Soy is clearly just good for you."

However, it is crucial to acknowledge the limitations of these observational studies. They establish a correlation but cannot definitively prove causation. Individuals who consume higher amounts of natto and other soy products may also adhere to other healthier lifestyle choices, such as regular exercise, a balanced diet, and lower rates of smoking, all of which independently contribute to better cardiovascular health. Therefore, disentangling the specific impact of natto from these confounding factors is challenging.

The Role of Vitamin K2: A Synergistic Factor?

Another potential contributor to natto’s cardiovascular benefits is its rich content of vitamin K2, particularly the MK-7 form. Research has indicated that vitamin K2 plays a role in directing calcium away from arteries and towards bones. A randomized controlled trial demonstrated that vitamin K2 supplementation appeared to slow the progression of coronary artery calcification by approximately 40%, although it did not reverse existing calcification. Given that most concentrated nattokinase supplements are devoid of vitamin K2, the synergistic effect between nattokinase and vitamin K2 in whole natto is a compelling area of inquiry. Mic the Vegan speculates, "I can’t help but wonder if the K2 and the nattokinase are working together."

Examining the Evidence: Can Nattokinase Directly Reduce Arterial Plaque?

The most captivating, yet controversial, claims surrounding nattokinase stem from a human study involving around 1,000 participants who consumed nattokinase for 12 months. This study reported a remarkable 36% reduction in carotid artery plaque, as measured by Doppler ultrasound. Mic the Vegan describes these results as "quite shocking" but immediately flags critical methodological concerns. He points out that the study was neither randomized nor placebo-controlled, rendering it susceptible to bias.

Furthermore, a significant conflict of interest was identified, as most of the study’s authors were financially compensated by a company that manufactures nattokinase supplements. While this does not automatically invalidate the findings, it underscores the critical need for independent replication.

In contrast, another randomized controlled trial, spanning three years, found no significant plaque reduction. However, this study utilized a lower dose of nattokinase (2,000 units), which was the same dosage that failed to demonstrate plaque reduction in the aforementioned larger study. Mic the Vegan concludes, "If it had 10,000, then we’d have a real answer. We don’t have a real answer. We need more research."

Animal studies have consistently shown reductions in arterial lesions, but direct extrapolation to humans is cautioned against. Rodents possess different metabolic rates, plaque characteristics, and often undergo extreme dietary or genetic modifications in experimental settings, making direct comparisons with human physiology unreliable.

The Biochemical Mechanisms: How Might Nattokinase Influence Fibrin and Clotting?

The scientific interest in nattokinase is partly fueled by its apparent ability to interact with fibrin, a protein integral to blood clot formation. Mic the Vegan likens the enzyme’s action to "a little pair of scissors," capable of breaking down fibrin without compromising the integrity of collagen or elastin in healthy vascular tissue.

Nattokinase may also enhance the activity of plasmin, one of the body’s natural fibrin-dissolving enzymes. This dual action – directly breaking down fibrin and bolstering the body’s own fibrinolytic processes – is described as a "one-two punch." As Mic explains, "it’s cutting the fibrin directly and then it is helping increase plasmin, which is cutting the fibrin also."

However, this mechanism does not automatically translate to dismantling established arterial plaque. Fibrin in fresh blood clots is readily accessible to circulating blood. In contrast, fibrin within long-standing plaque is often encased by a collagen-rich cap, hindering direct access for nattokinase circulating in the bloodstream. Therefore, any impact on older, established lesions might be more dependent on the body’s endogenous plasmin system.

Calcified plaque presents an even greater challenge. Mic describes these plaques as "almost more akin to bone." While less prone to rupture, they can still impede blood flow over time. Consequently, the most plausible potential benefit of nattokinase might be related to softer plaques and clot-related processes rather than significantly impacting heavily calcified arteries.

Navigating the Landscape: Promising, But Not Yet Proven

The very properties that make nattokinase scientifically intriguing also necessitate a cautious approach to its supplementation. Research indicates that even a single oral dose of nattokinase can influence clotting and coagulation factors, and it exhibits anti-platelet effects. Mic the Vegan strongly advises, "Of course, you want to talk to your doctor before taking this," particularly for individuals on medications that affect blood viscosity or clotting.

Warnings against nattokinase use in the two weeks preceding surgery due to a potential increased risk of bleeding are also highlighted. Despite these precautions, the available human evidence generally suggests that nattokinase is "quite safe and well tolerated" for the general population. However, the critical caveat remains: there is insufficient robust scientific evidence to definitively determine its efficacy for healthy individuals seeking to reduce arterial plaque.

Mic the Vegan’s overarching conclusion is one of measured optimism tempered by scientific rigor: "This is promising but not proven." He reiterates that animal research does not always translate to human outcomes, the most compelling human findings originate from industry-funded studies, and the only randomized trial to date utilized a lower, potentially ineffective dose.

Currently, the widespread claims linking nattokinase to the shrinking of arterial plaque outpace the established scientific evidence. While the possibility remains that high doses of nattokinase could indeed lead to significant plaque reduction over time, this remains an intriguing hypothesis awaiting confirmation. Until larger, independent, high-dose trials are conducted, nattokinase should be viewed as a promising area of research rather than a definitively proven solution for arterial plaque reduction.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making any decisions related to your health or treatment.